Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 29 November 2022 Biocartis Announces 55.91% of Offered Shares Subscribed at Closing of the Rights Subscription Period for Holders of Preferential Rights, and Start of the Sale of the Scrips through a Private Placement to Institutional Investors Inside information Regulated information 28 November 2022 Expected Mandatory Conversion Bondholder Notification Regulated information 14 November 2022 Results of the Extraordinary Shareholders’ Meeting held on 14 November 2022 Regulated information 8 November 2022 New Idylla™ EGFR Study Shows Reduction of Time-to-Treatment by 48% for Lung Cancer Patients Non-regulated information 31 October 2022 Biocartis Announces Nine Idylla™ Studies to be Published at Upcoming AMP 2022 Annual Meeting Non-regulated information 31 October 2022 Biocartis Announces Completion of Exchange Offer for its Existing Convertible Bonds, and issuance of New Convertible Bonds Regulated information 28 October 2022 Biocartis Announces Conversion of a Portion of the Convertible Term Loan into New Shares and Discloses Outstanding Voting Securities Regulated information 28 October 2022 Invitation to the Extraordinary Shareholders’ Meeting Regulated information 27 October 2022 Results of the Extraordinary Shareholders’ Meeting held on 27 October 2022 Regulated information 21 October 2022 Biocartis Reports Results of Third Quarter of 2022 Inside information Regulated information Pagination First page « First Previous page ‹‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page ›› Last page Last »